Submissions from 2023
IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation, Ahmad Ozair and Manmeet Ahluwalia
IMMU-34 Systemic Immune Suppression in Glioblastoma is Targeted by Concurrent VEGF and PD-1 Inhibition in a Dose-Dependent Manner: Transcriptomic Findings Through CITE-Seq from a Randomized Controlled Trial, Ahmad Ozair, Atulya Khosla, Shreyas Bellur, Michael McDermott, and Manmeet Ahluwalia
A study on inter-planner plan quality variability using a manual planning- or Lightning dose optimizer-approach for single brain lesions treated with the Gamma Knife(®) Icon™, Cecilia Lee, D Jay Wieczorek, Vibha Chaswal, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Michael McDermott, Alonso Gutierrez, and Ranjini Tolakanahalli
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways, Minesh Mehta, Matthew Hall, Doured Daghistani, and Yazmin Odia
Clinical trial implementation: a primer for neurosurgeons, Rupesh Kotecha
Radiation induced taste changes in head and neck cancer - differential impact of treatment factors, Tiffany Nong, Tammy Medrano, Muni Rubens, Adeel Kaiser, and Noah Kalman
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling, Minesh Mehta
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results, Guenther Koehne
Immune Checkpoint Inhibition and Single Fraction Stereotactic Radiosurgery in Brain Metastases from Non-Small Cell Lung Cancer: An International Multicenter Study of 395 Patients, Ahmad Ozair, Atulya Khosla, and Manmeet Ahluwalia
Integration and dosimetric validation of a dynamic collimation system for pencil beam scanning proton therapy, Alonso Gutiérrez
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma, Manmeet Ahluwalia
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda
Artificial intelligence in laparoscopic simulation: a promising future for large-scale automated evaluations, Domenech Asbun
Ablative 5-fraction CT- versus MR-guided pancreatic SBRT: dosimetric effects of interfraction anatomic change, Michael Chuong, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Diane Alvarez, Nema Bassiri-Gharb, Alonso Gutierrez, James McCulloch, Kathryn Mittauer, Nicole McAllister, Ashley Fellows, Amy Rzepczynski, and Will Deere
A comparative evaluation of different radiosurgery management strategies for large brain metastases: What is the optimal treatment paradigm?, Tugce Kutuk, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Anshul Saxena, Alonso La Rosa de los Rios, Martin Tom, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Mukesh Roy
Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis, Alonso La Rosa de los Rios, Surya Chundru, Martin Tom, Tugce Kutuk, D Jay Wieczorek, Muni Rubens, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Dosimetric evaluation of a novel non-metallic dual port expander for proton therapy, Joseph Panoff, Zachary Fellows, Andrew Wroe, and Kristen McConnell
Healthcare expenditure trends among adult stroke patients in the United States, 2011-2020, Venkataraghavan Ramamoorthy, Mukesh Roy, Anshul Saxena, Md Ashfaq Ahmed, Zhenwei Zhang, Peter McGranaghan, Michael McDermott, Felipe De Los Rios La Rosa, and Muni Rubens